首页> 外文期刊>Anaerobe >In vitro activity of ramoplamn and comparator drugs against anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora
【24h】

In vitro activity of ramoplamn and comparator drugs against anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora

机译:从涉及肠道菌群的病理学潜在用途的角度看,雷莫普兰和比较药物对厌氧性肠道细菌的体外活性

获取原文
获取原文并翻译 | 示例
       

摘要

Susceptibility of intestinal bacteria to various antimicrobial agents in vitro, together with levels of those agents achieved in the gut, provides information on the likely impact of the agents on the intestinal flora. Orally administered drugs that are poorly absorbed may be useful for treatment of intestinal infections and for certain other situations in which intestinal bacteria may play a role. The antimicrobial activity of ramoplanin (MDL 62,198) against 928 strains of intestinal anaerobic bacteria was determined using the NCCLS-approved Wadsworth brucella laked-blood agar dilution method. The activity of ramoplanin was compared with that of ampicillin, bacitracin, metronidazole, trimethoprim/sulfamethoxazole (TMP/SMX), and vancomycin. The organisms tested included Bacteroides fragilis group (n = 89), other Bacteroides species (n = 16), other anaerobic Gram-negative rods (n = 56) anaerobic cocci (n=114), Clostridium species (n = 426), and non-sporeforming anaerobic Gram-positive rods (n = 227). The overall MIC_(90)S of ramoplanin, ampicillin, bacitracin, metronidazole, and vancomycin were 256, 32, 128, 16, and 128 meg/ml, respectively.Ramoplanin was almost always highly active vs. Gram-positive organisms and relatively poor in activity against Gram-negative organisms, particularly Bacteroides, Bilophila, Prevotella, and Veillonella. Vancomycin was quite similar to ramoplanin in its activity. Ampicillin was relatively poor in activity vs. organisms that often produce beta-lactamase, including most of the Gram-negative rods as well as Clostridium bolteae and C. clostridioforme. Bacitracin was relatively poor in activity against most anaerobic Gram-negative rods, but better vs. most Gram-positive organisms. Metronidazole was very active against all groups other than bifidobacteria and some strains of other types of non-sporeforming Gram-positive bacilli. TMP/SMX was very poorly active, with an MIC_(90) of > 2048 meg/ml.
机译:肠道细菌对各种抗微生物剂的体外敏感性以及在肠道中达到的那些水平,提供了有关这些剂对肠道菌群可能影响的信息。口服吸收不良的药物可能对治疗肠道感染和某些其他可能在肠道细菌中起作用的情况有用。使用NCCLS批准的Wadsworth brucella湖血琼脂稀释法测定了雷莫拉宁(MDL 62,198)对928株肠道厌氧菌的抗菌活性。将雷莫拉宁的活性与氨苄青霉素,杆菌肽,甲硝唑,甲氧苄啶/磺胺甲恶唑(TMP / SMX)和万古霉素的活性进行了比较。所测试的生物包括脆弱的拟杆菌(n = 89),其他拟杆菌(n = 16),其他厌氧革兰氏阴性菌(n = 56)厌氧球菌(n = 114),梭状芽胞杆菌(n = 426)和非孢子形成的厌氧革兰氏阳性棒(n = 227)。雷莫拉宁,氨苄青霉素,杆菌肽,甲硝唑和万古霉素的总MIC_(90)S分别为256、32、128、16和128 mcg / ml。相对于革兰氏阳性生物,雷莫拉宁几乎总是高活性的,相对较差对革兰氏阴性生物,尤其是拟杆菌,嗜盐菌,普雷沃特氏菌和韦永氏菌具有抗性。万古霉素的活性与雷莫拉宁非常相似。与经常产生β-内酰胺酶的生物相比,氨苄西林的活性相对较差,包括大多数革兰氏阴性菌杆,博氏梭状芽胞杆菌和梭状梭状芽孢杆菌。杆菌肽对大多数厌氧革兰氏阴性菌的活性相对较弱,但比大多数革兰氏阳性菌更好。甲硝唑对除双歧杆菌和其他类型的非孢子形成革兰氏阳性杆菌的某些菌株以外的所有其他物种都非常活跃。 TMP / SMX的活性非常差,MIC_(90)大于2048mcg / ml。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号